Canada markets closed

BioMarin Pharmaceutical Inc. (BMRN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
80.91-1.26 (-1.53%)
At close: 04:00PM EDT
80.89 -0.02 (-0.02%)
After hours: 07:48PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 15.35B
Enterprise Value 15.40B
Trailing P/E 76.33
Forward P/E 30.40
PEG Ratio (5 yr expected) 0.69
Price/Sales (ttm)6.31
Price/Book (mrq)3.03
Enterprise Value/Revenue 6.23
Enterprise Value/EBITDA 42.86

Trading Information

Stock Price History

Beta (5Y Monthly) 0.32
52-Week Change 3-16.57%
S&P500 52-Week Change 322.36%
52 Week High 399.56
52 Week Low 376.02
50-Day Moving Average 387.60
200-Day Moving Average 389.06

Share Statistics

Avg Vol (3 month) 31.53M
Avg Vol (10 day) 32.15M
Shares Outstanding 5189.78M
Implied Shares Outstanding 6191.52M
Float 8188.32M
% Held by Insiders 10.84%
% Held by Institutions 1100.87%
Shares Short (Apr 15, 2024) 43.69M
Short Ratio (Apr 15, 2024) 42.76
Short % of Float (Apr 15, 2024) 41.96%
Short % of Shares Outstanding (Apr 15, 2024) 41.94%
Shares Short (prior month Mar 15, 2024) 42.96M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 8.31%
Operating Margin (ttm)12.62%

Management Effectiveness

Return on Assets (ttm)1.78%
Return on Equity (ttm)4.22%

Income Statement

Revenue (ttm)2.47B
Revenue Per Share (ttm)13.12
Quarterly Revenue Growth (yoy)8.80%
Gross Profit (ttm)N/A
EBITDA 294.77M
Net Income Avi to Common (ttm)205.46M
Diluted EPS (ttm)1.06
Quarterly Earnings Growth (yoy)74.40%

Balance Sheet

Total Cash (mrq)1.05B
Total Cash Per Share (mrq)5.51
Total Debt (mrq)1.09B
Total Debt/Equity (mrq)21.44%
Current Ratio (mrq)2.74
Book Value Per Share (mrq)26.74

Cash Flow Statement

Operating Cash Flow (ttm)280.16M
Levered Free Cash Flow (ttm)73.84M